iBB
46.3K views | +8 today
Follow
iBB
Institute for Bioengineering and Biosciences
Curated by iBB
Your new post is loading...
Your new post is loading...
Scoop.it!

Miguel Fuzeta to Defend PhD Thesis in Bioengineering

Miguel Fuzeta to Defend PhD Thesis in Bioengineering | iBB | Scoop.it

 Miguel de Almeida Fuzeta will be defending his PhD thesis in Bioengineering on Wednesday the 27th october 2021 at 10:00 h (https://videoconf-colibri.zoom.us/j/81143862412). During the last years, and under the supervision of Cláudia Lobato Silva from SCERG and BERG-IBB and Diana Maria Diez Gaspar from FEUP, Miguel focused his efforts on the development of Bioprocesses for the scalable manufacturing of extracellular vesicles derived from mesenchymal stromal cells. The title of the thesis is “Scalable Production of Extracellular Vesicles Derived from Mesenchymal Stromal Cells for Cancer-Targeted Drug Delivery”.

No comment yet.
Scoop.it!

Miguel Fuzeta Awarded EACR Meeting Bursary

Miguel Fuzeta Awarded EACR Meeting Bursary | iBB | Scoop.it

Miguel de Almeida Fuzeta from SCERG-iBB delivered an oral presentation at the Nanotechnology in Cancer: Engineering for Oncology conference, organized by the European Association for Cancer Research (EACR). At the conference, Miguel (5th from left in the picture) was awarded a travelling grant by EACR and Worldwide Cancer Research. In his presentation, entitled “Manufacturing Human Mesenchymal Stem/Stromal Cell (MSC)-Derived Extracellular Vesicles in Vertical-Wheel Bioreactors for Cancer Therapy” he reported his PhD work so far. The work involves a collaboration between researchers from iBB and iMM Lisboa, being supervised at IST by Prof. Cláudia Lobato da Silva and Dr. Nuno Bernardes. This conference gathered a multidisciplinary set of researchers using nanotechnology strategies for cancer therapy and diagnostics. The conference took place in Cambridge, United Kingdom on the 12-14th September.

No comment yet.
Scoop.it!

Production of Extracellular Vesicles Derived from Mesenchymal Stromal Cells in Bioreactors

Production of Extracellular Vesicles Derived from Mesenchymal Stromal Cells in Bioreactors | iBB | Scoop.it

Cell-based therapies have been showing unprecedented therapeutic potential, already changing the landscape of medical care. Extracellular vesicles are nanoparticles naturally secreted by cells, which are important mediators of intercellular communication in our organism and are able to mediate therapeutic effects from their cells of origin. These vesicles can also be used as drug delivery vehicles to target multiple diseases. In a paper recently published in Frontiers in Cell and Developmental Biology, iBB researchers in collaboration with iMM Lisboa, CQE-IST and the companies PBS Biotech and AventaCell Biomedical, developed a new strategy for the robust and scalable production of extracellular vesicles from mesenchymal stromal cells, using bioreactors and an animal serum-free cell culture supplement. This strategy, developed within the frame of the PhD Program in Bioengineering of Miguel de Almeida Fuzeta, is a relevant step towards the large scale production of extracellular vesicles form different human tissue sources, which are promising tools for the development of new therapies against a variety of diseases, from cardiovascular diseases to cancer.

No comment yet.